Suchergebnisse - "Nicastri, Emanuele"

PubPharm (509)

21

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

enthalten in: Preprints.org | 2023

von Del Duca, G. | Tavelli, A. | Mastrorosa, I. | +29

22

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region : A Cross-Sectional Analysis

enthalten in: Vaccines | 2023

von Del Duca, G. | Tavelli, A. | Mastrorosa, I. | +29

23

Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023 : preliminary investigation

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2023

von De Carli, G. | Carletti, F. | Spaziante, M. | +64

24

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection

enthalten in: Microorganisms | 2023

von Biava, M. | Notari, S. | Grassi, G. | +11

25

Convalescent Plasma Versus Hyperimmune Immunoglobulins

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Focosi, D. | Franchini, M. | Nicastri, E. | +2

CommentOn: Clin Infect Dis. 2023 Oct 5;77(7):964-971. - PMID 37220751

26

Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants

enthalten in: bioRxiv.org | 2023

von Iaconis, D. | Talarico, C. | Manelfi, C. | +11

27

Efficacy and safety of therapies for COVID-19 in pregnancy : a systematic review and meta-analysis

enthalten in: BMC infectious diseases | 2023

von Di Gennaro, F. | Guido, G. | Frallonardo, L. | +12

28

Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis

enthalten in: BMC infectious diseases | 2023

von Di Gennaro, F. | Guido, G. | Frallonardo, L. | +12

29

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

enthalten in: Vaccines | 2023

von Picchianti-Diamanti, A. | Navarra, A. | Aiello, A. | +27

30

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

enthalten in: Biomolecules | 2023

von Gruber, C. | Tucci, F. | Rueca, M. | +15